0000899243-23-017414.txt : 20230718
0000899243-23-017414.hdr.sgml : 20230718
20230718061006
ACCESSION NUMBER: 0000899243-23-017414
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230714
FILED AS OF DATE: 20230718
DATE AS OF CHANGE: 20230718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HUFF CURTIS W
CENTRAL INDEX KEY: 0001250127
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11460
FILM NUMBER: 231092975
MAIL ADDRESS:
STREET 1: 4510 LAMESA HWY
CITY: SNYDER
STATE: TX
ZIP: 79549
FORMER NAME:
FORMER CONFORMED NAME: HUFT CURTIS W
DATE OF NAME CHANGE: 20030628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freebird Investments LLC
CENTRAL INDEX KEY: 0001971406
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11460
FILM NUMBER: 231092976
BUSINESS ADDRESS:
STREET 1: 2800 POST OAK BLVD., SUITE 2000
CITY: HOUSTON
STATE: TX
ZIP: 77056
BUSINESS PHONE: 713-961-0118
MAIL ADDRESS:
STREET 1: 2800 POST OAK BLVD., SUITE 2000
CITY: HOUSTON
STATE: TX
ZIP: 77056
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freebird Partners LP
CENTRAL INDEX KEY: 0001955231
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11460
FILM NUMBER: 231092977
BUSINESS ADDRESS:
STREET 1: 2800 POST OAK BLVD.
STREET 2: SUITE 2000
CITY: HOUSTON
STATE: TX
ZIP: 77056
BUSINESS PHONE: 713-961-0118
MAIL ADDRESS:
STREET 1: 2800 POST OAK BLVD.
STREET 2: SUITE 2000
CITY: HOUSTON
STATE: TX
ZIP: 77056
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eterna Therapeutics Inc.
CENTRAL INDEX KEY: 0000748592
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 311103425
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1035 CAMBRIDGE STREET
STREET 2: SUITE 18A
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: (212) 582-1199
MAIL ADDRESS:
STREET 1: 10531 4S COMMONS DRIVE
STREET 2: SUITE 166-550
CITY: SAN DIEGO
STATE: CA
ZIP: 92127
FORMER COMPANY:
FORMER CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc.
DATE OF NAME CHANGE: 20210325
FORMER COMPANY:
FORMER CONFORMED NAME: NTN BUZZTIME INC
DATE OF NAME CHANGE: 20051230
FORMER COMPANY:
FORMER CONFORMED NAME: NTN COMMUNICATIONS INC
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-07-14
0
0000748592
Eterna Therapeutics Inc.
ERNA
0001955231
Freebird Partners LP
2800 POST OAK BLVD, SUITE 2000
HOUSTON
TX
77056
0
0
1
0
0001971406
Freebird Investments LLC
2800 POST OAK BLVD, SUITE 2000
HOUSTON
TX
77056
0
0
1
0
0001250127
HUFF CURTIS W
2800 POST OAK BLVD, SUITE 2000
HOUSTON
TX
77056
0
0
1
0
0
Convertible Note Shares
2.86
2023-07-14
4
P
0
262237
2.86
A
2023-07-14
2028-07-14
Common Stock, par value $0.005 per share
262237
262237
D
Common Stock Purchase Warrant
2.61
2023-07-14
4
P
0
524474
A
2023-07-14
2028-07-14
Common Stock, par value $0.005 per share
524474
949402
D
This report is filed jointly by Freebird Partners LP, a Texas limited partnership ("Freebird Partners"), Freebird Investments LLC, a Texas limited liability company ("Freebird Investments"), and Curtis W. Huff (each a "Reporting Person" and collectively, the "Reporting Persons") in connection with their respective direct and indirect ownership of common stock, par value $0.005 ("Common Stock") of Eterna Therapeutics Inc. (the "Company"). These securities of the Company are held of record by Freebird Partners. Freebird Investments serves as the general partner of Freebird Partners. Curtis W. Huff is the sole member of Freebird Investments. By virtue of these relationships, each of Freebird Investments and Mr. Huff may be deemed to share beneficial ownership of the securities held of record by Freebird Partners.
On July 13, 2023, Freebird Partners entered into that certain Securities Purchase Agreement (the "Agreement"), pursuant to which Freebird Partners agreed to purchase, and the Company agreed to sell, for an aggregate purchase price of $750,000, (i) a Senior Convertible Note in the principal amount of $750,000 (the "Note") with a five (5) year term, and (ii) a warrant to purchase up to 524,474 shares of Common Stock (the "Warrant" and such transactions the "Transactions". The Transactions closed on July 14, 2023. The Note may be converted at any time and from time to time after July 14, 2023, at the option of the holder, at a conversion price of $2.86 per share of Common Stock. The Warrant becomes exercisable on July 14, 2023, and may be exercised through July 14, 2028, at an exercise price of $2.61 per share of Common Stock.
Freebird Partners LP, By: Freebird Investments LLC, its general partner, By: /s/ Curtis W. Huff, Chairman and President
2023-07-17
Freebird Investments LLC, By: /s/ Curtis W. Huff, Chairman and President
2023-07-17
/s/ Curtis W. Huff
2023-07-17